Literature DB >> 22762398

Risk of venous thromboembolism outweighs post-hepatectomy bleeding complications: analysis of 5651 National Surgical Quality Improvement Program patients.

Ching-Wei D Tzeng1, Matthew H G Katz, Jason B Fleming, Peter W T Pisters, Jeffrey E Lee, Eddie K Abdalla, Steven A Curley, Jean-Nicolas Vauthey, Thomas A Aloia.   

Abstract

BACKGROUND: Historically, liver surgeons have withheld venous thromboembolism (VTE) chemoprophylaxis due to perceived postoperative bleeding risk and theorized protective anticoagulation effects of a hepatectomy. The relationships between extent of hepatectomy, postoperative VTE and bleeding events were evaluated using the National Surgical Quality Improvement Program (NSQIP) database.
METHODS: From 2005 to 2009, all elective open hepatectomies were identified. Factors associated with 30-day rates of VTE, postoperative transfusions and returns to the operating room (ROR), were analysed.
RESULTS: The analysis included 5651 hepatectomies with 3376 (59.7%) partial, 585 (10.4%) left, 1134 (20.1%) right, and 556 (9.8%) extended. Complications included deep vein thrombosis (DVT) (1.93%), pulmonary embolism (PE) (1.31%), venous thromboembolism (VTE) (2.88%), postoperative transfusion (0.76%) and ROR with transfusion (0.44%). VTE increased with magnitude of hepatectomy (partial 2.13%, left 2.05%, right 4.15%, extended 5.76%; P < 0.001) and outnumbered bleeding events (P < 0.001). Other factors independently associated with VTE were aspartate aminotransferase (AST) ≥27 (P= 0.022), American Society of Anesthesiologists (ASA) class ≥3 (P < 0.001), operative time >222 min (P= 0.043), organ space infection (P < 0.001) and length of hospital stay ≥7 days (P= 0.004). VTE resulted in 30-day mortality of 7.4% vs. 2.3% with no VTE (P= 0.001).
CONCLUSIONS: Contrary to the belief that transient postoperative liver insufficiency is protective, VTE increases with extent of hepatectomy. VTE exceeds major bleeding events and is strongly associated with mortality. These data support routine post-hepatectomy VTE chemoprophylaxis.
© 2012 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22762398      PMCID: PMC3406347          DOI: 10.1111/j.1477-2574.2012.00479.x

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  20 in total

1.  Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery.

Authors:  P Mismetti; S Laporte; J Y Darmon; A Buchmüller; H Decousus
Journal:  Br J Surg       Date:  2001-07       Impact factor: 6.939

2.  Prolonged prophylaxis with dalteparin to prevent late thromboembolic complications in patients undergoing major abdominal surgery: a multicenter randomized open-label study.

Authors:  M S Rasmussen; L N Jorgensen; P Wille-Jørgensen; J D Nielsen; A Horn; A C Mohn; L Sømod; B Olsen
Journal:  J Thromb Haemost       Date:  2006-08-01       Impact factor: 5.824

3.  Complications of elective liver resections in a center with low mortality: a simple score to predict morbidity.

Authors:  Axel Andres; Christian Toso; Bogdan Moldovan; Eduardo Schiffer; Laura Rubbia-Brandt; Sylvain Terraz; Claude E Klopfenstein; Philippe Morel; Pietro Majno; Gilles Mentha
Journal:  Arch Surg       Date:  2011-07-18

4.  Postoperative morbidity index: a quantitative measure of severity of postoperative complications.

Authors:  Steven M Strasberg; Bruce L Hall
Journal:  J Am Coll Surg       Date:  2011-08-25       Impact factor: 6.113

5.  Post-operative pharmacologic thromboprophylaxis after major hepatectomy: does peripheral venous thromboembolism prevention outweigh bleeding risks?

Authors:  Srinevas K Reddy; Ryan S Turley; Andrew S Barbas; Jennifer L Steel; Allan Tsung; J Wallis Marsh; Bryan M Clary; David A Geller
Journal:  J Gastrointest Surg       Date:  2011-06-21       Impact factor: 3.452

Review 6.  A systematic review of deep venous thrombosis prophylaxis in cancer patients: implications for improving quality.

Authors:  Michael J Leonardi; Marcia L McGory; Clifford Y Ko
Journal:  Ann Surg Oncol       Date:  2006-11-10       Impact factor: 5.344

7.  Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  William H Geerts; David Bergqvist; Graham F Pineo; John A Heit; Charles M Samama; Michael R Lassen; Clifford W Colwell
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

8.  Thromboelastogram monitoring in the perioperative period of hepatectomy for adult living liver donation.

Authors:  Elisabetta Cerutti; Chiara Stratta; Renato Romagnoli; Maria Maddalena Schellino; Stefano Skurzak; Mario Rizzetto; Giacomo Tamponi; Mauro Salizzoni
Journal:  Liver Transpl       Date:  2004-02       Impact factor: 5.799

9.  Predicting poor outcome following hepatectomy: analysis of 2313 hepatectomies in the NSQIP database.

Authors:  Thomas A Aloia; Bridget N Fahy; Craig P Fischer; Stephen L Jones; Andrea Duchini; Joseph Galati; A Osama Gaber; R Mark Ghobrial; Barbara L Bass
Journal:  HPB (Oxford)       Date:  2009-09       Impact factor: 3.647

Review 10.  Primary prevention of venous thromboembolism in medical and surgical oncology patients.

Authors:  A Stanley; A Young
Journal:  Br J Cancer       Date:  2010-04-13       Impact factor: 7.640

View more
  22 in total

1.  Safety of postoperative thromboprophylaxis after major hepatobiliary-pancreatic surgery in Japanese patients.

Authors:  Hiroki Hayashi; Takanori Morikawa; Hiroshi Yoshida; Fuyuhiko Motoi; Takaho Okada; Kei Nakagawa; Masamichi Mizuma; Takeshi Naitoh; Yu Katayose; Michiaki Unno
Journal:  Surg Today       Date:  2014-04-01       Impact factor: 2.549

Review 2.  Systematic review of pathophysiological changes following hepatic resection.

Authors:  Joey Siu; John McCall; Saxon Connor
Journal:  HPB (Oxford)       Date:  2013-08-29       Impact factor: 3.647

3.  Predictors of morbidity and mortality after hepatectomy in elderly patients: analysis of 7621 NSQIP patients.

Authors:  Ching-Wei D Tzeng; Amanda B Cooper; Jean-Nicolas Vauthey; Steven A Curley; Thomas A Aloia
Journal:  HPB (Oxford)       Date:  2013-08-26       Impact factor: 3.647

4.  Pharmacologic prophylaxis, postoperative INR, and risk of venous thromboembolism after hepatectomy.

Authors:  Hari Nathan; Matthew J Weiss; Gerald A Soff; Michelle Stempel; Ronald P Dematteo; Peter J Allen; T Peter Kingham; Yuman Fong; William R Jarnagin; Michael I D'Angelica
Journal:  J Gastrointest Surg       Date:  2013-10-16       Impact factor: 3.452

5.  Carrier-bound fibrin sealant compared to oxidized cellulose application after liver resection.

Authors:  Thomas Zacharias; Nelio Ferreira
Journal:  HPB (Oxford)       Date:  2012-09-21       Impact factor: 3.647

6.  Venous Thromboembolism Prophylaxis in Liver Surgery.

Authors:  Thomas A Aloia; William H Geerts; Bryan M Clary; Ryan W Day; Alan W Hemming; Luiz Carneiro D'Albuquerque; Charles M Vollmer; Jean-Nicolas Vauthey; Giles J Toogood
Journal:  J Gastrointest Surg       Date:  2016-01       Impact factor: 3.452

7.  Extended pharmacologic thromboprophylaxis in oncologic liver surgery is safe and effective.

Authors:  B J Kim; R W Day; C H Davis; N Narula; M H Kroll; C W D Tzeng; T A Aloia
Journal:  J Thromb Haemost       Date:  2017-09-27       Impact factor: 5.824

8.  Defining incidence and risk factors of venous thromboemolism after hepatectomy.

Authors:  Aslam Ejaz; Gaya Spolverato; Yuhree Kim; Donald L Lucas; Brandyn Lau; Matthew Weiss; Fabian M Johnston; Marin Kheng; Marian Kheng; Kenzo Hirose; Christopher L Wolfgang; Elliott Haut; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2013-12-13       Impact factor: 3.452

9.  Preoperative immunonutrition in liver resection-a propensity score matched case-control analysis.

Authors:  T Zacharias; N Ferreira; A-J Carin
Journal:  Eur J Clin Nutr       Date:  2014-06-25       Impact factor: 4.016

10.  Differences in Perioperative Outcomes Between Right and Left Hepatic Lobectomy.

Authors:  Jeffrey Douaiher; Mashaal Dhir; Lynette Smith; Chandrakanth Are
Journal:  Indian J Surg Oncol       Date:  2015-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.